When examining the published literature on the cost effectiveness of COPD treatments, the majority of studies identified perform pharmacoeconomic evaluations alongside clinical trials, using effectiveness and cost data collected prospectively over the course of the trial In a systematic review published in 2008, ten out of the 15 studies identified were evaluations alongside clinical trials and five were based on economic models .